Exact Sciences gains FDA approval for at-home colon cancer test

08/11/2014 | FoxNews.com

The FDA on Monday approved an at-home, DNA-based colorectal screening test from Exact Sciences that can spot genetic mutations linked to cancerous and precancerous growth in the colon. The Cologuard test was able to detect more cancers during clinical trials compared with blood testing. The test isn't meant to replace more thorough evaluation methods, such as colonoscopy, but rather to encourage more people to be screened, doctors say.

View Full Article in:

FoxNews.com

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Litigation & Investigations EMEA
Gilead Sciences
Stockely Park
Assistant General Counsel/Senior Corporate Counsel
Genentech
South San Francisco, CA
Senior Analyst Compliance
Edwards Lifesciences
Irvine, CA
Legal Counsel
Alcon
Fort Worth, TX
Director, Senior Legal Counsel
Alcon
Fort Worth, TX